Advisor Partners’s Allergan plc AGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-9,280
| Closed | -$1.64M | – | 721 |
|
|
2020
Q1 | $1.64M | Buy |
9,280
+2,642
| +40% | +$497K | 0.2% | 112 |
|
|
2019
Q4 | $1.29M | Buy |
6,638
+433
| +7% | +$78.1K | 0.13% | 154 |
|
|
2019
Q3 | $1.04M | Buy |
6,205
+3,595
| +138% | +$586K | 0.13% | 175 |
|
|
2019
Q2 | $437K | Sell |
2,610
-1,602
| -38% | -$222K | 0.05% | 346 |
|
|
2019
Q1 | $617K | Buy |
4,212
+1,188
| +39% | +$172K | 0.08% | 254 |
|
|
2018
Q4 | $404K | Sell |
3,024
-3,930
| -57% | -$644K | 0.06% | 329 |
|
|
2018
Q3 | $1.32M | Buy |
6,954
+1,318
| +23% | +$242K | 0.18% | 106 |
|
|
2018
Q2 | $940K | Buy |
5,636
+934
| +20% | +$150K | 0.16% | 145 |
|
|
2018
Q1 | $791K | Buy |
4,702
+514
| +12% | +$86.2K | 0.15% | 166 |
|
|
2017
Q4 | $759K | Sell |
4,188
-1,192
| -22% | -$214K | 0.14% | 174 |
|
|
2017
Q3 | $1.1M | Buy |
5,380
+188
| +4% | +$43.7K | 0.22% | 100 |
|
|
2017
Q2 | $1.26M | Sell |
5,192
-450
| -8% | -$106K | 0.3% | 84 |
|
|
2017
Q1 | $1.35M | Buy |
5,642
+1,799
| +47% | +$419K | 0.36% | 62 |
|
|
2016
Q4 | $807K | Sell |
3,843
-638
| -14% | -$132K | 0.24% | 108 |
|
|
2016
Q3 | $1.03M | Buy |
4,481
+386
| +9% | +$94.3K | 0.34% | 76 |
|
|
2016
Q2 | $946K | Buy |
4,095
+231
| +6% | +$53.3K | 0.33% | 80 |
|
|
2016
Q1 | $1.04M | Sell |
3,864
-840
| -18% | -$240K | 0.39% | 69 |
|
|
2015
Q4 | $1.47M | Buy |
4,704
+1,516
| +48% | +$451K | 0.5% | 53 |
|
|
2015
Q3 | $867K | Buy |
+3,188
| New | +$979K | 0.36% | 74 |
|
|
2015
Q2 | – | Sell |
-5,388
| Closed | -$1.6M | – | 327 |
|
|
2015
Q1 | $1.6M | Buy |
5,388
+1,652
| +44% | +$471K | 0.68% | 35 |
|
|
2014
Q4 | $948K | Buy |
3,736
+221
| +6% | +$55.2K | 0.42% | 70 |
|
|
2014
Q3 | $848K | Buy |
3,515
+2,509
| +249% | +$561K | 0.48% | 59 |
|
|
2014
Q2 | $224K | Buy |
+1,006
| New | +$208K | 0.11% | 243 |
|
Other funds holding AGN
AJ
C
B
JJ
VFA
OPS
Advisor Partners's AGN Position: Q2 2020 in Review
Advisor Partners sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 9,280 shares — an estimated $1.64M sold.
Advisor Partners first reported a position in AGN in Q2 2014 and held it in 23 quarters. The position peaked at $1.64M in Q1 2020. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.
- Advisor Partners reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
- Advisor Partners sold 9,280 Allergan plc shares in Q2 2020, an estimated $1.64M.
- Advisor Partners first reported a position in Allergan plc in Q2 2014 and held it in 23 quarters.
- Advisor Partners's Allergan plc position peaked at $1.64M in Q1 2020.
- 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.
Based on Advisor Partners's 13F filing for Q2 2020, filed 12 Aug 2020.